UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer

International journal of cancer, 2010-06, Vol.126 (12), p.2762-2772

2010

Volltextzugriff (PDF)

DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis

Cell, 2006-07, Vol.126 (1), p.121-134

2006

Volltextzugriff (PDF)

A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer

Cancer cell, 2011-07, Vol.20 (1), p.79-91

2011

Volltextzugriff (PDF)

Preliminary Assessment of Safety and Efficacy in Proof-of-Concept, Randomized Clinical Trial of Tanezumab for Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Urology (Ridgewood, N.J.), 2012-11, Vol.80 (5), p.1105-1110

2012

Volltextzugriff (PDF)

The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP

Nature structural & molecular biology, 2007-10, Vol.14 (10), p.912-920

2007

Volltextzugriff (PDF)

iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53

Nature genetics, 2006-10, Vol.38 (10), p.1133-1141

2006

Volltextzugriff (PDF)

Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum‐induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer

International journal of cancer, 2009-09, Vol.125 (6), p.1454-1463

2009

Volltextzugriff (PDF)

ASPP1 and ASPP2: Common Activators of p53 Family Members

Molecular and Cellular Biology, 2004-02, Vol.24 (3), p.1341-1350

2004

Volltextzugriff (PDF)

ASPP Proteins Specifically Stimulate the Apoptotic Function of p53

Molecular cell, 2001-10, Vol.8 (4), p.781-794

2001

Volltextzugriff (PDF)

Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control

Molecular oncology, 2015-04, Vol.9 (4), p.791-805

2015

Volltextzugriff (PDF)

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis

Cancer cell, 2003-04, Vol.3 (4), p.387-402

2003

Volltextzugriff (PDF)

In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion

Clinical cancer research, 2006-12, Vol.12 (23), p.7126-7131

2006

Volltextzugriff (PDF)

Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo

Oncogene, 2004-04, Vol.23 (19), p.3328-3337

2004

Volltextzugriff (PDF)

Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer

Cancer research (Chicago, Ill.), 2011-05, Vol.71 (9), p.3317-3327

2011

Volltextzugriff (PDF)

iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human

Nature genetics, 2003-02, Vol.33 (2), p.162-167

2003

Volltextzugriff (PDF)

Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies

Blood, 2006-01, Vol.107 (1), p.250-256

2006

Volltextzugriff (PDF)

Electronic Sculpting of Ligand-GPCR Subtype Selectivity: The Case of Angiotensin II

ACS chemical biology, 2014-07, Vol.9 (7), p.1420-1425

2014

Volltextzugriff (PDF)

Epigenetic Inactivation Implies Independent Functions for Insulin-like Growth Factor Binding Protein (IGFBP)-Related Protein 1 and the Related IGFBPL1 in Inhibiting Breast Cancer Phenotypes

Clinical cancer research, 2007-07, Vol.13 (14), p.4061-4068

2007

Volltextzugriff (PDF)

p53 family members and chemoresistance in cancer: what we know and what we need to know

Drug resistance updates, 2003-12, Vol.6 (6), p.323-328

2003

Volltextzugriff (PDF)

Concomitant inactivation of p53 and Chk2 in breast cancer

Oncogene, 2002-02, Vol.21 (9), p.1316-1324

2002

Volltextzugriff (PDF)

Spectrum of p53 Gene Mutations Suggests a Possible Role for Ultraviolet Radiation in the Pathogenesis of Advanced Cutaneous Lymphomas

Journal of investigative dermatology, 1999-03, Vol.112 (3), p.317-321

1999

Volltextzugriff (PDF)

Functional regulation of p73 and p63: development and cancer

Trends in biochemical sciences (Amsterdam. Regular ed.), 2003-12, Vol.28 (12), p.663-670

2003

Volltextzugriff (PDF)

Ser392 phosphorylation regulates the oncogenic function of mutant p53

Cancer research (Chicago, Ill.), 2004-07, Vol.64 (14), p.4749-4754

2004

Volltextzugriff (PDF)

Array-based DNA methylation profiling in follicular lymphoma

Leukemia, 2009-10, Vol.23 (10), p.1858-1866

2009

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(65)

Sprache

Englisch
(65)

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Life Sciences & Biomedicine
(59)
Humans
(55)
Female
(25)
Biological And Medical Sciences
(23)
Infectious Diseases
(17)
Medical Sciences
(17)
Microbiology
(15)
Male
(14)
Cell Biology
(12)
Mutation
(12)
Oncology
(12)
Animals
(11)
Biochemistry & Molecular Biology
(11)
Cell Line, Tumor
(11)
Middle Aged
(11)
Mycobacterium Tuberculosis - Genetics
(10)
Adult
(9)
Aged
(9)
Tumor Suppressor Protein P53 - Metabolism
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer

DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis

A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer

Prognostic and Therapeutic Impact of Argininosuccinate Synthetase 1 Control in Bladder Cancer as Monitored Longitudinally by PET Imaging

Preliminary Assessment of Safety and Efficacy in Proof-of-Concept, Randomized Clinical Trial of Tanezumab for Chronic Prostatitis/Chronic Pelvic Pain Syndrome

The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP

iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53

Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum‐induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer

ASPP1 and ASPP2: Common Activators of p53 Family Members

ASPP Proteins Specifically Stimulate the Apoptotic Function of p53

Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis

In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion

Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo

Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer

iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human

Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies

Electronic Sculpting of Ligand-GPCR Subtype Selectivity: The Case of Angiotensin II

Epigenetic Inactivation Implies Independent Functions for Insulin-like Growth Factor Binding Protein (IGFBP)-Related Protein 1 and the Related IGFBPL1 in Inhibiting Breast Cancer Phenotypes

p53 family members and chemoresistance in cancer: what we know and what we need to know

Concomitant inactivation of p53 and Chk2 in breast cancer

Spectrum of p53 Gene Mutations Suggests a Possible Role for Ultraviolet Radiation in the Pathogenesis of Advanced Cutaneous Lymphomas

Functional regulation of p73 and p63: development and cancer

Ser392 phosphorylation regulates the oncogenic function of mutant p53

Array-based DNA methylation profiling in follicular lymphoma

Aktive Filter

Suchergebnisse filtern